Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2004 2
2006 1
2007 1
2008 2
2010 2
2011 2
2012 3
2013 2
2014 3
2015 2
2016 8
2017 10
2018 8
2019 12
2020 31
2021 33
2022 23
2023 17
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.
Rivellese F, Surace AEA, Goldmann K, Sciacca E, Çubuk C, Giorli G, John CR, Nerviani A, Fossati-Jimack L, Thorborn G, Ahmed M, Prediletto E, Church SE, Hudson BM, Warren SE, McKeigue PM, Humby F, Bombardieri M, Barnes MR, Lewis MJ, Pitzalis C; R4RA collaborative group. Rivellese F, et al. Nat Med. 2022 Jun;28(6):1256-1268. doi: 10.1038/s41591-022-01789-0. Epub 2022 May 19. Nat Med. 2022. PMID: 35589854 Free PMC article. Clinical Trial.
Biomarkers in Systemic Sclerosis: An Overview.
Di Maggio G, Confalonieri P, Salton F, Trotta L, Ruggero L, Kodric M, Geri P, Hughes M, Bellan M, Gilio M, Lerda S, Baratella E, Confalonieri M, Mondini L, Ruaro B. Di Maggio G, et al. Among authors: bellan m. Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490. Curr Issues Mol Biol. 2023. PMID: 37886934 Free PMC article. Review.
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, Nerviani A, Giorli G, Mahto A, Montecucco C, Lauwerys B, Ng N, Ho P, Bombardieri M, Romão VC, Verschueren P, Kelly S, Sainaghi PP, Gendi N, Dasgupta B, Cauli A, Reynolds P, Cañete JD, Moots R, Taylor PC, Edwards CJ, Isaacs J, Sasieni P, Choy E, Pitzalis C; R4RA collaborative group. Humby F, et al. Lancet. 2021 Jan 23;397(10271):305-317. doi: 10.1016/S0140-6736(20)32341-2. Lancet. 2021. PMID: 33485455 Free PMC article. Clinical Trial.
COVID‑19: different waves and different outcomes.
Patrucco F, Bellan M, Solidoro P. Patrucco F, et al. Among authors: bellan m. Pol Arch Intern Med. 2022 Oct 21;132(10):16352. doi: 10.20452/pamw.16352. Epub 2022 Oct 21. Pol Arch Intern Med. 2022. PMID: 36268805 Free article. No abstract available.
Lessons from the Italian COVID-19 frontline.
Bellan M, Sainaghi PP, Gavelli F, Patrucco F, Avanzi GC, Pirisi M, Castello LM. Bellan M, et al. Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1. Minerva Med. 2020. PMID: 33032392 Free article. No abstract available.
From MASH to HCC: the role of Gas6/TAM receptors.
Apostolo D, Ferreira LL, Vincenzi F, Vercellino N, Minisini R, Latini F, Ferrari B, Burlone ME, Pirisi M, Bellan M. Apostolo D, et al. Among authors: bellan m. Front Immunol. 2024 Jan 17;15:1332818. doi: 10.3389/fimmu.2024.1332818. eCollection 2024. Front Immunol. 2024. PMID: 38298195 Free PMC article. Review.
Circadian variations in the elderly: A scoping review.
Ferreira LL, Rosatto N, Marzullo P, Bellan M. Ferreira LL, et al. Among authors: bellan m. Chronobiol Int. 2024 Mar;41(3):311-328. doi: 10.1080/07420528.2024.2327456. Epub 2024 Mar 19. Chronobiol Int. 2024. PMID: 38501270 Review.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
The Gas6/TAM System and Multiple Sclerosis.
Bellan M, Pirisi M, Sainaghi PP. Bellan M, et al. Int J Mol Sci. 2016 Oct 28;17(11):1807. doi: 10.3390/ijms17111807. Int J Mol Sci. 2016. PMID: 27801848 Free PMC article. Review.
Vitamin D in Systemic Sclerosis: A Review.
Perazzi M, Gallina E, Manfredi GF, Patrucco F, Acquaviva A, Colangelo D, Pirisi M, Bellan M. Perazzi M, et al. Among authors: bellan m. Nutrients. 2022 Sep 21;14(19):3908. doi: 10.3390/nu14193908. Nutrients. 2022. PMID: 36235561 Free PMC article. Review.
160 results